LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), TRAPS AND HIDS/MKD: RESULTS FROM THE PIVOTAL PHASE 3 CLUSTER TRIAL


Creative Commons License

De Benedetti F., Frenkel J., Simon A., Anton J., Lachmann H., Gattorno M., ...More

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.486-487, (Summary Text) identifier